Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV
Clinical trial NCT05052996 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05052996
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2023-12-19
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.